Arq. Bras. Oftalmol. 2019; 82 (1): 10.5935/0004-2749.20190004
Total: 1197
Vasco Bravo-Filho1,2,3; Patrick Logan1; Pablo Zoroquiain1; Sultan Aldrees1; Natàlia Vilà1; Ayman Oweida4; Rubens Belfort Neto2; Miguel N. Burnier Jr1,2
DOI: 10.5935/0004-2749.20190004
1. The Henry C. Witelson Ocular Pathology Laboratory, McGill University, Montreal, Quebec, Canada
2. Ophthalmology and Visual Sciences Department, Universidade Federal de São Paulo, São Paulo, SP, Brazil
3. Ophthalmology Department, Fundação Altino Ventura, Recife, PE, Brazil
4. Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
Vasco Bravo-Filho
Rua Arnoldo Magalhães, 22/602
Recife, PE - 52051-280 - Brazil
E-mail: [email protected]
Funding: This study was supported by the Pan-American Ophthalmology Association 2013 Sean Murphy Ocular Pathology Fellowship and by CAPES (Coordenação de Aperfeiçoamento Profissional de Nível Superior, Ministério da Educação/Brasil)
Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
